M45.3

Clinical Causes: Genetic predisposition, particularly the presence of the HLA-B27 gene Environmental factors that may trigger autoimmune responses Genetic susceptibility combined with environmental triggers leads to immune system malfunctions Possible links to other inflammatory or autoimmune conditions

Key Symptoms: Persistent stiffness and pain in the neck and upper back Reduced flexibility in the cervical and thoracic spine Chronic discomfort that worsens with rest and improves with activity Fatigue and general feelings of tiredness Postural changes, such as a forward-stooped neck In advanced cases, fusion of affected vertebrae leading to a reduced range of motion Occasional inflammation in other joints or organs

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and diagnostic tests. Physicians typically perform a physical examination to assess flexibility, pain points, and posture. Imaging studies like X-rays, MRI, or CT scans can reveal the characteristic changes such as sacroiliitis or spinal fusion. Blood tests may check for markers of inflammation and the presence of the HLA-B27 gene, which is associated with a higher risk of ankylosing spondylitis.

Treatment Protocols: While there is no cure for ankylosing spondylitis, various treatments aim to manage symptoms and prevent progression. These include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain - Physical therapy to maintain flexibility and posture - Regular exercise, focusing on stretching and strengthening the back muscles - Biologic medications, such as TNF-alpha inhibitors, in more severe cases - Lifestyle adjustments including ergonomic modifications and smoking cessation - In some cases, surgical intervention may be considered for severe joint damage or deformities